myelofibrosis: updates on jak inhibitors
Published 2 years ago • 107 plays • Length 3:23Download video MP4
Download video MP3
Similar videos
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
1:39
treating patients with myelofibrosis who are intolerant to or develop resistance to jak inhibitors
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
13:48
understanding treatment options for et, pv, and myelofibrosis
-
7:10
bomedemstat in jak inhibitor-resistant myelofibrosis
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
3:51
future jak inhibitor combination approaches in myelofibrosis
-
3:21
manifest: ruxolitinib plus pelabresib for jak-inhibitor naïve myelofibrosis
-
4:25
update on momelotinib for myelofibrosis
-
2:21
recent updates on pelabresib for myelofibrosis
-
2:04
novel therapies for myelofibrosis patients who have failed jak inhibitors
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
1:01
latest advances in myelofibrosis treatment
-
0:51
the need for disease-modifying drugs in myelofibrosis
-
1:01
clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
-
3:51
new therapies for myelofibrosis
-
2:22
boreas: krt-232 in patients with myelofibrosis r/r to jak inhibitors